• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN:帕金森病治疗的新曙光。

PTEN: a new dawn in Parkinson's disease treatment.

作者信息

Yang Xinghuang, Liu Tianqi, Cheng Hong

机构信息

Medical College, Yangzhou University, Yangzhou, China.

Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research, Yangzhou University Medical College, Institute of Translational Medicine, Yangzhou University, Yangzhou, China.

出版信息

Front Cell Neurosci. 2025 Mar 10;19:1497555. doi: 10.3389/fncel.2025.1497555. eCollection 2025.

DOI:10.3389/fncel.2025.1497555
PMID:40129459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931041/
Abstract

In recent years, the study of phosphatase and tension homolog (PTEN) has gradually become a research hotspot. As an important oncogene, the role of PTEN in cancer has long been widely recognized and intensively studied, but it has been relatively less studied in other diseases. Parkinson's disease (PD) is a neurodegenerative refractory disease commonly observed in middle-aged and elderly individuals. The etiology and pathogenesis of PD are numerous, complex, and incompletely understood. With the continuous deepening of research, numerous studies have proven that PTEN is related to the occurrence of PD. In this review, we discuss the relationship between PTEN and PD through the phosphorylation and ubiquitination of PTEN and other possible regulatory mechanisms, including the role of RNA molecules, exosomes, transcriptional regulation, chemical modification, and subtype variation, with the aim of clarifying the regulatory role of PTEN in PD and better elucidating its pathogenesis. Finally, we summarize the shortcomings of PTEN in PD research and highlight the great potential of its future application in PD clinical treatment. These findings provide research ideas and new perspectives for the possible use of PTEN as a PD therapeutic target for targeted drug development and clinical application in the future.

摘要

近年来,磷酸酶与张力蛋白同源物(PTEN)的研究逐渐成为一个研究热点。作为一种重要的抑癌基因,PTEN在癌症中的作用早已得到广泛认可并被深入研究,但在其他疾病中的研究相对较少。帕金森病(PD)是一种常见于中老年人的神经退行性难治性疾病。PD的病因和发病机制众多、复杂且尚未完全明确。随着研究的不断深入,大量研究已证明PTEN与PD的发生有关。在这篇综述中,我们通过PTEN的磷酸化和泛素化以及其他可能的调控机制,包括RNA分子、外泌体、转录调控、化学修饰和亚型变异的作用,来探讨PTEN与PD之间的关系,旨在阐明PTEN在PD中的调控作用并更好地阐明其发病机制。最后,我们总结了PTEN在PD研究中的不足之处,并强调了其未来在PD临床治疗中应用的巨大潜力。这些发现为未来可能将PTEN用作PD治疗靶点进行靶向药物开发和临床应用提供了研究思路和新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/fc6d875bcd8b/fncel-19-1497555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/a8e963650d31/fncel-19-1497555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/83a2a415599a/fncel-19-1497555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/69fccbfb8d93/fncel-19-1497555-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/fc6d875bcd8b/fncel-19-1497555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/a8e963650d31/fncel-19-1497555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/83a2a415599a/fncel-19-1497555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/69fccbfb8d93/fncel-19-1497555-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f41/11931041/fc6d875bcd8b/fncel-19-1497555-g004.jpg

相似文献

1
PTEN: a new dawn in Parkinson's disease treatment.PTEN:帕金森病治疗的新曙光。
Front Cell Neurosci. 2025 Mar 10;19:1497555. doi: 10.3389/fncel.2025.1497555. eCollection 2025.
2
MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.微小RNA-181b通过靶向磷酸酶和张力蛋白同源物/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路调控帕金森病模型中的自噬。
Neurosci Lett. 2018 May 14;675:83-88. doi: 10.1016/j.neulet.2018.03.041. Epub 2018 Mar 30.
3
Roles of PTEN with DNA Repair in Parkinson's Disease.PTEN在帕金森病中与DNA修复的作用。
Int J Mol Sci. 2016 Jun 15;17(6):954. doi: 10.3390/ijms17060954.
4
Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.帕金森病患者黑质区域中核磷酸酶和张力蛋白同源物(PTEN)水平升高及胰岛素信号改变。
Neurosci Lett. 2018 Feb 14;666:139-143. doi: 10.1016/j.neulet.2017.12.049. Epub 2017 Dec 26.
5
MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.miR-410 通过抑制 PTEN/AKT/mTOR 信号通路在 6-羟多巴胺诱导的帕金森病细胞模型中发挥神经保护作用。
Exp Mol Pathol. 2019 Aug;109:16-24. doi: 10.1016/j.yexmp.2019.05.002. Epub 2019 May 5.
6
Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.从DJ-1到PTEN的转亚硝基化作用可减轻帕金森病模型中的神经元细胞死亡。
J Neurosci. 2014 Nov 5;34(45):15123-31. doi: 10.1523/JNEUROSCI.4751-13.2014.
7
SNHG1 promotes MPP-induced cytotoxicity by regulating PTEN/AKT/mTOR signaling pathway in SH-SY5Y cells via sponging miR-153-3p.SNHG1 通过海绵吸附 miR-153-3p 调控 PTEN/AKT/mTOR 信号通路促进 MPP+诱导的 SH-SY5Y 细胞毒性。
Biol Res. 2020 Jan 6;53(1):1. doi: 10.1186/s40659-019-0267-y.
8
Mitochondrial Hydrogen Peroxide Activates PTEN and Inactivates Akt Leading to Autophagy Inhibition-Dependent Cell Death in Neuronal Models of Parkinson's Disease.线粒体过氧化氢激活 PTEN 并失活 Akt,导致帕金森病神经元模型中自噬抑制依赖性细胞死亡。
Mol Neurobiol. 2023 Jun;60(6):3345-3364. doi: 10.1007/s12035-023-03286-y. Epub 2023 Feb 28.
9
Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling Events.PTEN 的药理学抑制通过减轻凋亡和神经炎症信号事件来挽救多巴胺能神经元。
J Neuroimmune Pharmacol. 2023 Sep;18(3):462-475. doi: 10.1007/s11481-023-10077-8. Epub 2023 Aug 17.
10
[Progress of researches on the role of oxidative stress in acupuncture treatment of Parkinson's disease].[氧化应激在针刺治疗帕金森病中作用的研究进展]
Zhen Ci Yan Jiu. 2024;49(9):985-992. doi: 10.13702/j.1000-0607.20230094.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.额颞叶痴呆、阿尔茨海默病和帕金森病中的共享及疾病特异性通路。
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833-1.

本文引用的文献

1
A molecular glue for PRKN/parkin.一种针对PRKN/帕金蛋白的分子胶。
Autophagy. 2025 Mar;21(3):689-690. doi: 10.1080/15548627.2024.2443232. Epub 2024 Dec 24.
2
Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.缺乏 parkin 会导致猴模型中的神经退行性变和病理性 α-突触核蛋白的积累。
J Clin Invest. 2024 Oct 15;134(20):e179633. doi: 10.1172/JCI179633.
3
PTEN controls alternative splicing of autism spectrum disorder-associated transcripts in primary neurons.PTEN 控制原代神经元中自闭症谱系障碍相关转录本的可变剪接。
Brain. 2025 Jan 7;148(1):47-54. doi: 10.1093/brain/awae306.
4
Role of AMBRA1 in mitophagy regulation: emerging evidence in aging-related diseases.AMBRA1 在调控自噬中的作用:与衰老相关疾病的新证据。
Autophagy. 2024 Dec;20(12):2602-2615. doi: 10.1080/15548627.2024.2389474. Epub 2024 Sep 2.
5
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.基因靶向试验时代基因检测的相关性:罗斯托克帕金森病研究
Brain. 2024 Aug 1;147(8):2652-2667. doi: 10.1093/brain/awae188.
6
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.帕金森病变异检测与披露:北美研究项目“PD基因计划”
Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.
7
Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue.开发和鉴定磷酸泛素抗体,以监测细胞和组织中的 PINK1-PRKN 信号转导。
Autophagy. 2024 Sep;20(9):2076-2091. doi: 10.1080/15548627.2024.2356490. Epub 2024 May 27.
8
Spatially Precise Genetic Engineering at the Electrode-Tissue Interface.电极-组织界面的空间精确基因工程
Adv Mater. 2024 Jul;36(29):e2401327. doi: 10.1002/adma.202401327. Epub 2024 May 8.
9
Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR/microtubule pathway.中线蛋白 1 通过 mTOR/微管途径调节实验性自身免疫性脑脊髓炎效应 T 细胞的迁移运动。
Theranostics. 2024 Jan 20;14(3):1168-1180. doi: 10.7150/thno.87130. eCollection 2024.
10
Medical, surgical, and physical treatments for Parkinson's disease.帕金森病的医学、手术和物理治疗。
Lancet. 2024 Jan 20;403(10423):305-324. doi: 10.1016/S0140-6736(23)01429-0.